Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

358
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering Gaps in Obesity Medicine Competencies: Insights from Ten U.S. Medical Schools.

Medical science educator·2026
Same author

Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: Clinical Efficacy, Safety, and Place in Therapy.

The Annals of pharmacotherapy·2026
Same author

The Enduring Impact of a Health Promotion Educational Program for Medical Professionals.

American journal of lifestyle medicine·2026
Same author

Characteristics and Philosophies of Family Physician Leaders: A Qualitative Investigation.

PRiMER (Leawood, Kan.)·2026
Same author

Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2026
Same author

Using Artificial Intelligence for Identifying Quality Improvement Interventions in Clinical Medical Clerkships: AI for QI.

Medical science educator·2025
Same journal

Skin Cancer: Management of Cutaneous Melanoma.

FP essentials·2026
Same journal

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

FP essentials·2026
Same journal

Skin Cancer: Diagnosis.

FP essentials·2026
Same journal

Skin Cancer: Screening and Prevention.

FP essentials·2026
Same journal

Skin Cancer.

FP essentials·2026
Same journal

Obesity Management: Surgical Interventions.

FP essentials·2026
See all related articles

Related Experiment Video

Updated: Nov 6, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K

Diabetes: Type 1 Diabetes.

Magdalena Pasarica1, Erin St Onge2, Ernestine Lee3

  • 1University of Central Florida College of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827.

FP Essentials
|May 10, 2021
PubMed
Summary
This summary is machine-generated.

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to hyperglycemia. Management includes insulin therapy, medical nutrition, and screening for complications.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.0K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.7K

Related Experiment Videos

Last Updated: Nov 6, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.0K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.7K

Area of Science:

  • Endocrinology
  • Immunology
  • Metabolic Diseases

Background:

  • Type 1 diabetes (T1D) is an autoimmune condition characterized by pancreatic beta-cell destruction and subsequent insulin deficiency, leading to hyperglycemia.
  • The general population risk is 0.5%, with increased risk factors including family history and co-existing autoimmune diseases.
  • Current American Diabetes Association (ADA) guidelines recommend screening for T1D autoimmune markers in research settings for asymptomatic individuals.

Purpose of the Study:

  • To outline the definition, risk factors, and current management strategies for Type 1 diabetes.
  • To highlight the importance of screening, education, and comprehensive care in managing T1D.
  • To discuss the role of medical nutrition therapy and pharmacologic interventions in T1D management.

Main Methods:

  • Review of current literature and clinical guidelines regarding Type 1 diabetes diagnosis and management.
  • Analysis of risk factors, including genetic predisposition and autoimmune markers.
  • Evaluation of therapeutic approaches, including insulin regimens, adjunct therapies, and lifestyle interventions.

Main Results:

  • Medical nutrition therapy can reduce A1c by up to 1.9% in T1D patients.
  • Insulin therapy typically involves a basal-bolus regimen (50% basal, 50% bolus).
  • Pramlintide is the sole FDA-approved adjunct to insulin therapy for T1D.

Conclusions:

  • Type 1 diabetes requires lifelong management focusing on glycemic control, insulin replacement, and complication screening.
  • Integrated care involving diabetes self-management education and medical nutrition therapy is crucial.
  • Regular screening for associated conditions like hypertension is essential for optimal patient outcomes.